multiplex PCR
The Spanish company last week announced that it raised €13 million in Series B financing to fund its efforts to supplant culture-based methods with molecular testing.
Company researchers recently demonstrated the attributes of the research-use-only system in a 43-target, two-tube multiplex dPCR test for EGFR mutations.
Becton Dickinson Gets CE-IVD Mark for BD Max Combined COVID, Flu, RSV Panel
The firm also plans to submit the assay to the US Food and Drug Administration for Emergency Use Authorization in the coming weeks.
BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel
The panel includes additional pathogen targets and resistance genes, as well as revised targets compared to the original BCID panel.
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.